Lineage Cell Therapeutics
(AMEX:LCTX)

GET A REPORT ON LCTX SENT RIGHT TO YOUR INBOX

37.5%
Overview Rating
Unpromising asset
Technicals Analysis
66
0100
Financials Analysis
20
0100

Lineage Cell Therapeutics Stock (AMEX:LCTX), Quotes and News Summary

Lineage Cell Therapeutics Stock (AMEX: LCTX) stock price, news, charts, stock research, profile.
Open$1.030
Close$1.040
Volume / Avg.431.054K / 778.404K
Day Range1.030 - 1.060
52 Wk Range0.841 - 1.569
Market Cap$194.133M
P/E Ratio-
Dividend Yield-
ExchangeAMEX
RSI
47
Short Interest
%
Days to Cover14.36
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Feb
2
Strong Buy
Buy
Hold
Sell
Strong Sell
About Lineage Cell Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development a...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LCTX

FAQ

Q

How do I buy Lineage Cell Therapeutics (LCTX) stock?

A

You can purchase shares of Lineage Cell Therapeutics (AMEX: LCTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lineage Cell Therapeutics's (LCTX) competitors?

A

There are no as such competitors for Lineage Cell Therapeutics.

Q

What is the target price for Lineage Cell Therapeutics (LCTX) stock?

A

The latest price target for Lineage Cell Therapeutics (AMEX: LCTX) was reported by HC Wainwright & Co. on Tuesday, February 13, 2024. The analyst firm set a price target for 7.00 expecting LCTX to fall to within 12 months (a possible NaN% downside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lineage Cell Therapeutics (LCTX)?

A

The stock price for Lineage Cell Therapeutics (AMEX: LCTX) is $ last updated .

Q

Does Lineage Cell Therapeutics (LCTX) pay a dividend?

A

There are no upcoming dividends for Lineage Cell Therapeutics.

Q

When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?

A

Lineage Cell Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Lineage Cell Therapeutics (LCTX) going to split?

A

There is no upcoming split for Lineage Cell Therapeutics.

Q

What sector and industry does Lineage Cell Therapeutics (LCTX) operate in?

A

Lineage Cell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch